Impact of Prophylactic High Flow Nasal Oxygen in Post-Operative Thoracic Surgical Patients

Completed · Not applicable

Conditions studied: Post-operative Pulmonary Complications

In brief

The Investigators goal was to study the effect of high flow nasal cannula oxygen (HFNC) on the rate of post-operative pulmonary complications in thoracic surgical patients. The Investigators hypothesis is that prophylactic HFNC oxygen, as compared to standard oxygen treatment, will reduce the incidence of postoperative pulmonary complications, improve post-operative pulmonary function, and reduce Intensive Care Unit (ICU) and hospital length of stay.

Key facts

Study ID

NCT03024112

Run by

University of Colorado, Denver

People needed

51

Starts

2013-08-01

Expected to finish

2015-06-01

Last updated by the study team

2026-07-07

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Undergoing Thoracic surgery
• Planned admission to ICU after surgery

You may not qualify if…

• Younger than 18
• Pregnant
• Breast feeding
• Known diagnosis of obstructive sleep apnea
• Current or previous lung transplant
• Pneumonectomy
• Home oxygen greater than 4L/minute
• Inability to adhere to assigned treatment prior to 48 hours of surgery or until transferred to a floor

Where it is running

• Unversity of Colorado Hospital — Aurora, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.